Description

BRUFEN 200 MG

Indications

BRUFEN 200 MG, containing the active ingredient ibuprofen, is a non-steroidal anti-inflammatory drug (NSAID) commonly used for the relief of mild to moderate pain, inflammation, and fever. It is indicated for conditions such as headaches, dental pain, menstrual cramps, muscle aches, and arthritis. Additionally, BRUFEN may be used to alleviate pain associated with various inflammatory conditions, making it a versatile option in pain management.

Mechanism of Action

The therapeutic effects of BRUFEN 200 MG are primarily attributed to its ability to inhibit the cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. These enzymes are crucial in the biosynthesis of prostaglandins, which are lipid compounds that play a significant role in the inflammatory response, pain sensation, and regulation of body temperature. By blocking the action of COX enzymes, BRUFEN reduces the production of prostaglandins, leading to decreased inflammation, pain relief, and antipyretic effects.

Pharmacological Properties

BRUFEN 200 MG is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations typically reached within 1 to 2 hours after oral administration. The drug has a bioavailability of approximately 80%, and its effects can last for several hours, making it suitable for both acute and chronic conditions. The volume of distribution is approximately 0.1 to 0.2 L/kg, and ibuprofen is highly protein-bound (about 90-95%), primarily to albumin. The drug is metabolized in the liver, and its elimination half-life ranges from 1.8 to 2.5 hours. Renal excretion is the primary route for the elimination of ibuprofen and its metabolites.

Contraindications

BRUFEN 200 MG is contraindicated in individuals with a known hypersensitivity to ibuprofen or any of its components. It should not be used in patients with a history of gastrointestinal bleeding or perforation related to previous NSAID therapy, active peptic ulcer disease, or severe renal impairment. Additionally, it is contraindicated during the third trimester of pregnancy due to the risk of fetal cardiovascular effects. Patients with a history of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs should also avoid using BRUFEN.

Side Effects

While BRUFEN 200 MG is generally well-tolerated, it may cause side effects in some individuals. Common side effects include gastrointestinal disturbances such as nausea, vomiting, diarrhea, constipation, and dyspepsia. More serious side effects can occur, including gastrointestinal bleeding, renal impairment, and allergic reactions such as rash, itching, or anaphylaxis. Patients should be advised to seek medical attention if they experience symptoms such as severe abdominal pain, black or bloody stools, or difficulty breathing.

Dosage and Administration

The recommended dosage of BRUFEN 200 MG varies depending on the condition being treated. For adults, the typical dose is 200 to 400 mg every 4 to 6 hours as needed, not exceeding 1200 mg per day without medical supervision. For children, the dosage is based on body weight, typically ranging from 5 to 10 mg/kg per dose, with a maximum daily dose of 40 mg/kg. It is advisable to take BRUFEN with food or milk to minimize gastrointestinal irritation. Patients should follow the specific dosage instructions provided by their healthcare provider or as indicated on the product label.

Interactions

BRUFEN 200 MG may interact with various medications, which can alter its effectiveness or increase the risk of adverse effects. Notable interactions include anticoagulants (e.g., warfarin), which may increase the risk of bleeding; other NSAIDs, which can enhance gastrointestinal toxicity; and certain antihypertensive medications (e.g., ACE inhibitors and diuretics), which may have reduced efficacy when taken concurrently with ibuprofen. It is essential for patients to inform their healthcare provider of all medications they are taking to avoid potential interactions.

Precautions

Before using BRUFEN 200 MG, patients should consider several precautions. Individuals with a history of cardiovascular disease, hypertension, or liver impairment should use this medication with caution, as it may exacerbate these conditions. Elderly patients are also at a higher risk for adverse effects and may require dosage adjustments. It is advisable to monitor renal function, especially in patients with pre-existing kidney issues. Pregnant or breastfeeding women should consult their healthcare provider before using BRUFEN to weigh the potential benefits against risks.

Clinical Studies

Numerous clinical studies have evaluated the efficacy and safety of ibuprofen, including BRUFEN 200 MG, in various conditions. Research has demonstrated that ibuprofen is effective in reducing pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, and acute musculoskeletal injuries. Studies have also shown that ibuprofen is comparable to other NSAIDs and analgesics in managing postoperative pain and dental pain. The overall safety profile of ibuprofen has been established through extensive use in clinical practice, with adverse effects generally being mild and manageable.

Conclusion

BRUFEN 200 MG is a widely used NSAID that provides effective relief for pain, inflammation, and fever. Its mechanism of action involves the inhibition of COX enzymes, leading to reduced prostaglandin synthesis. While generally safe for most patients, it is essential to consider contraindications, potential side effects, and drug interactions. Proper dosing and administration are crucial for maximizing therapeutic benefits while minimizing risks. As with any medication, patients should consult their healthcare provider for personalized advice and guidance regarding the use of BRUFEN.